Continental Advisors’s Pfizer PFE Stock Holding History

Continental Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-46,376	Closed	-$1.49M	–	154
2016 Q3	$1.49M	Buy	+46,376	New	+$1.55M	0.42%	73

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Continental Advisors's PFE Position: Q1 2026 in Review

Continental Advisors reduced its Pfizer (PFE) stake by 3.6% in Q1 2026, selling an estimated $386K and leaving 386,438 shares worth $10.9M. The position accounts for 5.54% of the portfolio, ranked #4.

Continental Advisors first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Continental Advisors held 386,438 shares of Pfizer worth $10.9M as of Q1 2026.
Continental Advisors sold 14,500 Pfizer shares in Q1 2026, an estimated $386K.
Pfizer made up 5.54% of Continental Advisors's portfolio in Q1 2026, its #4 holding.
Continental Advisors first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Continental Advisors's 13F filing for Q1 2026, filed 15 May 2026.